Leading the shift to intelligent, connected, patient-centred health.
Dr Sophia Moscovis is a scientist, strategist, and healthcare leader with more than twenty years of experience across academia, clinical trials, biotechnology, pharmaceuticals, and digital health.
She holds a Bachelor of Biomedical Science with First Class Honours, a PhD in Immunology and Genetics, and is a Graduate of the Australian Institute of Company Directors.
Sophia has held senior leadership roles at Novartis, where she built deep expertise in healthcare systems, patient engagement, digital transformation, and health innovation. She has also advised Global Fortune 500 pharmaceutical companies on strategy, change leadership, and patient-centred models of care.
She is currently the Vice President of Operations and Strategy at Race Oncology, an ASX-listed biotech, where she leads corporate strategy, governance, risk, and operational excellence.
A recognised voice in Australia’s HealthTech ecosystem, Sophia serves on the BioNSW Digital Health and Technology Committee, is a Board Observer for AusBiotech, contributes to Forbes Australia, and advises emerging digital-health ventures. She is also the co-founder and CEO of Lumie Health, a startup empowering individuals to collect, store, and understand their health data using agentic AI.
Talking Points
The Future of Healthcare: AI, Personalised Data, and the Digitally-Enabled Patient
Healthcare is undergoing the most significant transformation in its history. Advances in AI, digital health, and real-time data are shifting healthcare from reactive and fragmented to predictive, personalised, and patient-centred. Individuals can now understand their bodies in real time, while clinicians are supported by intelligent systems that enhance decision-making, safety, and outcomes.The Future of Healthcare: AI, Personalised Data, and the Digitally-Enabled Patient
This keynote explores how emerging technologies — from wearable data to clinical records, genomics, and agentic AI — are converging to create a world where health information is unified, meaningful, and actionable.
Key Takeaways:
• The rise of digital biomarkers and continuous health monitoring
• Real-time AI analysis for personalised insights
• Preventative, data-driven healthcare models
• The shift toward patient-owned, interoperable health data
• How organisations can prepare for the next decade of digital health innovation
Who Is This For:
Organisations in healthcare, insurance, pharma, life sciences, digital transformation, government, and technology seeking to understand how AI and data will redefine healthcare delivery and patient experience.
AI, Data, and the New Frontier of Digital Health Innovation
Beyond simple automation, AI is redefining healthcare workflows, diagnostics, operations, and population health. Agentic AI, predictive modelling, and advanced analytics are reshaping how organisations make decisions, deliver care, and create value.AI, Data, and the New Frontier of Digital Health Innovation
This keynote demystifies how AI is being safely and effectively integrated into healthcare systems — from hospitals and biotech to insurers and consumer health.
Key Takeaways:
• Agentic AI: what it is and why it matters
• Predictive models, risk forecasting, and precision care
• How AI augments clinicians, improves safety, and reduces burnout
• Ethical, regulatory, and governance considerations
• Practical steps for organisations to adopt AI responsibly
Who Is This For:
Healthcare providers, insurers, pharma/biotech, digital health companies, hospital executives, and organisations exploring AI strategy, implementation, and innovation.
Web3, Digital Trust & The Future of Health Data Ownership
While hype has faded, the core technologies of Web3 — blockchain, decentralised identity, and digital ownership — are quietly shaping the next era of health data integrity and trust. This session explores how decentralised technologies are enabling secure data sharing, improved consent models, immutable audit trails, and new patient-centred architectures.Web3, Digital Trust & The Future of Health Data Ownership
Key Takeaways:
• Blockchain for health data integrity and secure exchange
• Decentralised identity and patient-controlled data access
• Smart contracts for consent, payments, and data governance
• Practical use cases beyond the hype
Who Is This For:
Industries exploring digital trust, data governance, secure system design, cybersecurity, decentralisation, and next-generation digital health.
Reinventing Yourself: How to Navigate Redundancy, Reinvention & Building a Multi-Portfolio Career
Sophia shares the real story behind her career transformation — from redundancy after ten years at one company, to rebuilding a multi-portfolio career in just two months. She went on to become a pharmaceutical executive, HealthTech founder, advisor to Fortune 500 healthcare companies, Forbes Australia contributor, and a leader in Australia’s digital-health ecosystem.Reinventing Yourself: How to Navigate Redundancy, Reinvention & Building a Multi-Portfolio Career
This keynote is raw, inspirational, and deeply practical.
Key Takeaways:
• Mindset tools for reinvention: self-belief, resilience, grit
• How to navigate uncertainty, setbacks, and major change
• Leadership foundations: humility, purpose, transparency, vulnerability
• Entrepreneurial skills: networking, design thinking, partnerships, community
• Building a career with meaning, adaptability, and long-term growth
Who Is This For:
Business leaders, executives, founders, startups, women in leadership, graduates, and organisations undergoing change, restructuring, or transformation.
The Convergence of Biotech, AI & Digital Health
As a biotech executive and digital health founder, Sophia bridges two worlds that are rapidly merging. This keynote reveals how AI, molecular science, digital platforms, and real-time data are converging to advance cancer therapeutics, improve drug development efficiency, and elevate patient care.The Convergence of Biotech, AI & Digital Health
Key Takeaways:
• How AI is reshaping R&D, CMC, clinical trials, and patient insights
• The new era of precision therapeutics
• How digital health strengthens drug development and patient outcomes
• Preparing organisations for hybrid biotech–digital futures
Who Is This For:
Pharma, biotech, hospitals, investors, policy, and anyone interested in the future of therapeutics and healthcare innovation.
Latest News
Neale Daniher: A Legacy That Will Outlast The Beast
Three Stories, One Expert: What Dr Zac Seidler's Week in the Media Tells Us About Men Right Now
How to Measure Event ROI: Why 72% of the Industry Says Outcome Measurement Is Now Essential
